Klick Health

Overview

Klick Health is a large independent life-sciences marketing and commercialization agency for pharmaceutical, biotech, and medical-device brands. It is best read as an integrated health agency with a meaningful technology and market-access layer, not as a standalone hub, CRM, payer contracting advisor, or evidence-generation vendor; the Peregrine Market Access acquisition adds an access-communications lane to diligence.

For launch teams, Klick is most relevant when brand strategy, HCP and patient engagement, medical / scientific content, MLR-sensitive workflow, media activation, measurement, and payer / access communications need to move through one operating model. The Peregrine Market Access acquisition gives Klick a stronger access-communications lane, while its AI tools make MLR, message testing, market insights, and campaign operations important diligence topics.

Healthcare Marketing Comms Capability Model

The framework below standardizes how Rx Almanac evaluates healthcare-marketing-comms capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Klick Health is evaluated as an integrated health agency with a meaningful technology and market-access layer, not as a standalone hub, CRM, payer contracting advisor, or evidence-generation vendor; the Peregrine Market Access acquisition adds an access-communications lane to diligence.

Capability	Buyer should compare	Klick Health readout
Brand strategy and launch planning	Positioning, segmentation, message architecture, launch sequencing, campaign platform, and brand planning.	Core launch-planning work. Klick is a broad health-agency partner for brand strategy, campaign development, launch planning, and commercialization support across established pharma and emerging biotech accounts.
HCP media and omnichannel activation	HCP targeting, media, point-of-care, digital, social, congress, rep-triggered, and CRM-connected activation.	Core engagement model. Klick combines creative, media, digital, and omnichannel execution; buyers should test how HCP targeting, media buying, CRM triggers, and partner data are governed in the proposed scope.
Payer, access, and market access communications	Payer tools, value messages, reimbursement content, access pull-through, and patient-services communications.	Documented, strengthened by Peregrine. Peregrine Market Access adds payer insight, value communications, HEOR-oriented messaging, and access strategy. Validate whether pricing / contracting strategy or hub operations are in scope or handled elsewhere.
Medical/clinical content and MLR operations	Clinical story, claims support, MLR workflows, medical education, scientific accuracy, and compliant content operations.	Core medical-content workflow. Klick’s public positioning emphasizes scientific and medical depth, while AI-enabled review and insight tools make claims support, traceability, and MLR governance key diligence areas.
Measurement, targeting, and optimization	Audience data, campaign analytics, attribution, test-and-learn loops, and performance optimization.	Core analytics use case. Klick is a stronger fit when media, insights, and campaign optimization sit close to creative execution. Buyers should clarify which data assets are proprietary, licensed, or partner-sourced.
Agency integration and execution capacity	Creative, media, PR, medical, access, production, localization, and account-service capacity.	Core agency execution model. Klick’s model is positioned around integrated agency delivery across creative, medical, media, access, technology, and analytics. Global and APAC coverage should be validated for each launch market.

Buyer Fit

• Shortlist when: Include Klick when a launch needs one agency to connect brand strategy, creative, HCP / patient engagement, media, medical content, and access communications.
• Strongest use cases: Integrated brand launches, HCP and patient omnichannel campaigns, MLR-sensitive content operations, access-aware communications, medical / scientific storytelling, and AI-assisted message or insight workflows.
• Market access fit: Peregrine makes Klick more credible for payer and value-communications work, but buyers should separately scope pricing, contracting, gross-to-net, payer research, and patient-support operations.
• Therapy and product fit: Current metadata points to oncology, rare disease, immunology / autoimmune, neurology, cardiology, and women’s health, with biologic, specialty, and small-molecule fit.
• Commercial fit: Pricing is Custom/RFP, so assume an RFP-led scope with service levels, data feeds, launch timing, and governance defined in the statement of work.
• Integration diligence: Confirm the actual team, therapy analogs, MLR workflow, media transparency, AI governance, data dependencies, global / local market coverage, and the boundary between Klick-owned work and partner or manufacturer-owned systems.

Differentiators

• Integrated health-agency scale: Klick can cover strategy, creative, medical, media, analytics, and commercialization work inside one health-specialist agency model.
• Peregrine Market Access: The January 2025 acquisition adds a dedicated payer / access communications bench for value messaging, reimbursement strategy support, and access pull-through content.
• AI-enabled workflow: Publicly announced tools such as HCP AI FocusGroup, InsightFull, Guardrail, KCM+AI, and Site AiQ make AI governance, claims traceability, and workflow integration real RFP topics rather than generic innovation claims.
• Creative recognition: Public awards coverage reinforces Klick’s creative reputation, which matters when differentiation and disease-state education are central to launch strategy.
• APAC expansion signal: The Ward6 Singapore transaction gives Klick a stronger Asia-Pacific foothold, but buyers should still validate local-market staff, language coverage, regulatory review, and media execution.

RFP Questions

• What therapy, launch, and market-access analogs does the actual team bring?
• How will HCP, patient, payer, medical, and field communications stay consistent without slowing MLR?
• Which AI tools will be used in the engagement, what evidence trail do they produce, and how are outputs reviewed before MLR submission?
• Which targeting, identity, media, measurement, and audience assets are proprietary versus partner-sourced?
• How transparent will media buying, partner fees, optimization logic, and performance reporting be to the manufacturer?
• Which responsibilities does Peregrine own access work directly, and where would Klick expect a separate pricing, contracting, HEOR, or hub partner?
• What execution capacity is available after strategy, and where will the manufacturer need other agencies or internal systems?
• How will global / APAC execution be staffed, localized, and governed?

Recent Activity

• May 2026: Klick announced additional award recognition for its “18 Months” campaign during Creative Week.
• January 2025: Acquired Peregrine Market Access, adding market access strategy, HEOR-oriented communications, and payer engagement capability.
• March 2025: Acquired Ward6’s Singapore operations, expanding Asia-Pacific presence.
• 2025: Announced AI-enabled workflow and insights products including HCP AI FocusGroup, InsightFull, Guardrail, and related life-sciences marketing tools.
• 2024-2025: Added senior leaders across medical, strategy, creative, oncology, analytics, market access, media, and global execution roles.